Sanofi Deal-Making Aimed At Changing Oncology R&D, Zerhouni Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The French drug maker announced deals with Warp Drive Bio and Innate Pharma on the opening day of J.P. Morgan, research collaborations intended to reenergize the company’s come-from-behind position in oncology.